156 related articles for article (PubMed ID: 32946961)
1. Mechanisms dissection of the combination GRS derived from ShengMai preparations for the treatment of myocardial ischemia/reperfusion injury.
Yang W; Lai Q; Zhang L; Zhang Y; Zhang Y; Yu B; Li F; Kou J
J Ethnopharmacol; 2021 Jan; 264():113381. PubMed ID: 32946961
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission.
Li F; Fan X; Zhang Y; Pang L; Ma X; Song M; Kou J; Yu B
Sci Rep; 2016 Nov; 6():37114. PubMed ID: 27869201
[TBL] [Abstract][Full Text] [Related]
3. A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.
Li F; Fan XX; Chu C; Zhang Y; Kou JP; Yu BY
Cell Physiol Biochem; 2018; 45(4):1455-1471. PubMed ID: 29466787
[TBL] [Abstract][Full Text] [Related]
4. Schisandrol A Attenuates Myocardial Ischemia/Reperfusion-Induced Myocardial Apoptosis through Upregulation of 14-3-3
Gong S; Liu J; Wan S; Yang W; Zhang Y; Yu B; Li F; Kou J
Oxid Med Cell Longev; 2021; 2021():5541753. PubMed ID: 34257806
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Zhan S; Guo W; Shao Q; Fan X; Li Z; Cheng Y
J Ethnopharmacol; 2014 Mar; 152(2):333-9. PubMed ID: 24462784
[TBL] [Abstract][Full Text] [Related]
7. Protective role of deoxyschizandrin and schisantherin A against myocardial ischemia-reperfusion injury in rats.
Chang R; Li Y; Yang X; Yue Y; Dou L; Wang Y; Zhang W; Li X
PLoS One; 2013; 8(4):e61590. PubMed ID: 23620773
[TBL] [Abstract][Full Text] [Related]
8. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury.
Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y
Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659
[TBL] [Abstract][Full Text] [Related]
9. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy.
Wu S; Chang G; Gao L; Jiang D; Wang L; Li G; Luo X; Qin S; Guo X; Zhang D
J Mol Med (Berl); 2018 Aug; 96(8):791-806. PubMed ID: 29955901
[TBL] [Abstract][Full Text] [Related]
10. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
11. An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases.
Li F; Lv YN; Tan YS; Shen K; Zhai KF; Chen HL; Kou JP; Yu BY
Acta Pharmacol Sin; 2015 Nov; 36(11):1337-48. PubMed ID: 26456587
[TBL] [Abstract][Full Text] [Related]
12. Oxypaeoniflorin improves myocardial ischemia/reperfusion injury by activating the Sirt1/Foxo1 signaling pathway.
Wang K; Hu W
Acta Biochim Pol; 2020 Jun; 67(2):239-245. PubMed ID: 32550708
[TBL] [Abstract][Full Text] [Related]
13. YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.
Li F; Zheng X; Fan X; Zhai K; Tan Y; Kou J; Yu B
Rejuvenation Res; 2016 Dec; 19(6):495-508. PubMed ID: 27072567
[TBL] [Abstract][Full Text] [Related]
14. Identification of schisandrin as a vascular endothelium protective component in YiQiFuMai Powder Injection using HUVECs binding and HPLC-DAD-Q-TOF-MS/MS analysis.
Li F; Tan YS; Chen HL; Yan Y; Zhai KF; Li DP; Kou JP; Yu BY
J Pharmacol Sci; 2015 Sep; 129(1):1-8. PubMed ID: 26452526
[TBL] [Abstract][Full Text] [Related]
15. Schisandrin B Prevents Hind Limb from Ischemia-Reperfusion-Induced Oxidative Stress and Inflammation via MAPK/NF-
Zhu N; Cai C; Zhou A; Zhao X; Xiang Y; Zeng C
Biomed Res Int; 2017; 2017():4237973. PubMed ID: 28706944
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats.
Chiu PY; Ko KM
Mol Cell Biochem; 2004 Nov; 266(1-2):139-44. PubMed ID: 15646035
[TBL] [Abstract][Full Text] [Related]
17. Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-κB signaling pathway inhibition.
Fan X; Elkin K; Shi Y; Zhang Z; Cheng Y; Gu J; Liang J; Wang C; Ji X
Neurol Res; 2020 Aug; 42(8):693-702. PubMed ID: 32657248
[TBL] [Abstract][Full Text] [Related]
18. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats.
Ren-an Q; Juan L; Chuyuan L; Wenjuan F; Chunyan H; Xuemei Y; Lin H; Hong N
J Ethnopharmacol; 2014 Oct; 156():190-8. PubMed ID: 25178948
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rb2 alleviates myocardial ischemia/reperfusion injury in rats through SIRT1 activation.
Xue Y; Fu W; Liu Y; Yu P; Sun M; Li X; Yu X; Sui D
J Food Sci; 2020 Nov; 85(11):4039-4049. PubMed ID: 33073372
[TBL] [Abstract][Full Text] [Related]
20. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury.
Wang Y; Che J; Zhao H; Tang J; Shi G
Biochem Biophys Res Commun; 2018 Sep; 503(4):3219-3224. PubMed ID: 30146261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
